About this trial
Outbreaks of seasonal respiratory viruses can spread rapidly in long-term care homes. Timely results for diagnostic tests remains a challenge for respiratory viruses due to the logistics of using a reference laboratory with delays leading to missed opportunities to implement virus-specific control measures to interrupt transmission resulting in larger outbreaks. Use of a point-of-care testing platform is a potential solution that provides faster results, but it is uncertain whether this translates into benefits for long-term care residents. This trial aims to assess whether rapid test results for respiratory pathogens (Influenza, Coronavirus disease of 2019 (COVID-19) and Respiratory Syncytial Virus) can impact the number and size of respiratory virus outbreaks in long-term care homes.
Eligibility criteria
Qualifiers
None
Disqualifiers
No signed statement of agreement for study participation
Pre-existing use of a point-of-care testing platform
Trial design
Treatments tested in this trial
- Point-of-care respiratory test platform
- Existing respiratory virus testing platform
Treatment groups
Sponsors and collaborators
Michael Garron Hospital
Lead sponsor
Sunnybrook Health Sciences Centre
Collaborator
Humber River Health
Collaborator